Kishony Lab

Technion - Israel Institute of Technology

- · Israel

ERC-funded
Rate this labNo reviews yet — be the first.

Research focus

ERC Advanced Grant · 2021

Microbiome centered prediction and prevention of recurrent infections

Antibiotics are a double-edged sword: they help clear the current infection, yet can also select for resistant pathogens, making future infections harder to treat. While treatment guidelines recognize this ‘collateral damage’, we currently lack strategies to predict how treatments affect future recurrence and resistance at the individual patient level. This problem is of particular importance in Urinary Tract Infections (UTIs); affecting the majority of women over their lifetime, UTIs can chronically recur despite antimicrobial treatment. Importantly, UTIs are often self-seeded by strains residing in the gut microbiome, suggesting that the gut microbiome may provide means to predict current…

From the public funding record at EU CORDIS. Describes the funded project, not the reviews below.

Reviews

← All labs at Technion - Israel Institute of Technology